Ilika plc
Reported: 2026-01-26
Ilika plc reported strong progress in its half-year results, highlighting milestone achievements in solid-state battery development and initial commercial orders, underpinning a solid foundation for future growth.
Key takeaways
- Successfully completed an equity raise, bolstering capital for operational stability and growth.
- Achieved initial commercial orders for Stereax batteries, indicating market acceptance and ramp-up in production.
- Goliath product line reached product prototyping stage, with ongoing trials to convert prototypes into minimum viable products for the EV and automotive sectors.
- Continued strong pipeline of intellectual property with 78 patents granted, enhancing the company's competitive positioning in solid-state battery technology.
- Established strategic collaboration with Cirtec Medical for Stereax, integrating battery solutions into broader power management systems for neurostimulation applications.
